This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Karen Klapper Lomas: Innovator in Pharmaceutical Formulation
Introduction
Karen Klapper Lomas is a notable inventor based in Wilmington, NC (US). She has made significant contributions to the field of pharmaceuticals, particularly with her innovative formulations. Her work has the potential to impact the way medications are delivered and absorbed in the body.
Latest Patents
Karen holds a patent for a pharmaceutical formulation that includes tamoxifen citrate. This formulation comprises from 5 to 15% by weight of tamoxifen citrate and a first disintegrant, which is croscarmellose sodium. The formulation is designed to ensure that, in six 20 mg unit doses, an average of at least 65 percent by weight of the tamoxifen citrate will dissolve within 10 minutes in 1000 mL of 0.02N hydrochloric acid at 37° C when stirred at 100 rpm. This innovation is crucial for enhancing the efficacy of tamoxifen citrate in therapeutic applications.
Career Highlights
Karen is associated with Eli Lilly and Company, a leading global pharmaceutical company. Her role there has allowed her to work on groundbreaking research and development projects. With her expertise, she has contributed to advancements in drug formulation and delivery systems.
Collaborations
Throughout her career, Karen has collaborated with esteemed colleagues, including Gordon Nelson Arbuthnot and Glenn A Meyer. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Karen Klapper Lomas exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions, particularly in the formulation of tamoxifen citrate, highlight her commitment to improving healthcare solutions. Her work continues to inspire future advancements in drug development.